Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 179.57M P/E - EPS this Y 30.20% Ern Qtrly Grth -
Income -132.49M Forward P/E -1.24 EPS next Y -3.80% 50D Avg Chg 8.00%
Sales 20.76M PEG -0.16 EPS past 5Y - 200D Avg Chg -33.00%
Dividend N/A Price/Book 0.68 EPS next 5Y 22.30% 52W High Chg -72.00%
Recommedations 2.10 Quick Ratio 6.21 Shares Outstanding 68.60M 52W Low Chg 41.00%
Insider Own 11.59% ROA -21.53% Shares Float 52.50M Beta 3.19
Inst Own 76.16% ROE -49.50% Shares Shorted/Prior 9.56M/5.29M Price 3.66
Gross Margin - Profit Margin - Avg. Volume 1,284,451 Target Price 18.50
Oper. Margin -1,147.72% Earnings Date May 2 Volume 404,974 Change -1.35%
About C4 Therapeutics, Inc.

C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. Its lead product candidate is CFT7455, an orally bioavailable MonoDAC degrader of protein that is in Phase 1/2 trial targeting IKZF1 and IKZF3 for multiple myeloma and non-Hodgkin lymphomas, including peripheral T-cell lymphoma and mantle cell lymphoma, currently under Phase 1/2 clinical trials. The company is also developing CFT1946, an orally bioavailable BiDAC degrader targeting V600X mutant BRAF to treat melanoma, non-small cell lung cancer (NSCLC), colorectal cancer, and other solid malignancies, currently under Phase 1/2 clinical trials; and CFT8919, an orally bioavailable, allosteric, and mutant-selective BiDAC degrader of epidermal growth factor receptor, or EGFR, with an L858R mutation in NSCLC. It has strategic collaborations with F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc.; Biogen MA, Inc.; Betta Pharmaceuticals, Co., Ltd.; and Merck Sharp & Dohme, LLC, as well as Calico Life Sciences LLC. The company was incorporated in 2015 and is headquartered in Watertown, Massachusetts.

C4 Therapeutics, Inc. News
04/29/24 C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
04/09/24 C4 Therapeutics to Participate in the Stifel 2024 Targeted Oncology Forum
04/08/24 C4 Therapeutics Presents New Preclinical Data for CFT1946 Highlighting Superior Activity as a Single Agent to Clinically Approved BRAF Inhibitor Standard of Care Combinations at the American Association for Cancer Research Annual Meeting 2024
03/28/24 Here’s Why Meridian Small Cap Growth Fund Trimmed C4 Therapeutics (CCCC)
03/05/24 C4 Therapeutics to Present New Preclinical Data on Highly Selective Orally Bioavailable BiDAC™ Degraders at the American Association for Cancer Research Annual Meeting 2024
03/04/24 C4 Therapeutics Announces Strategic Discovery Research Collaboration with Merck KGaA, Darmstadt, Germany, Against Critical Oncogenic Proteins
02/27/24 New Forecasts: Here's What Analysts Think The Future Holds For C4 Therapeutics, Inc. (NASDAQ:CCCC)
02/24/24 C4 Therapeutics Full Year 2023 Earnings: Misses Expectations
02/22/24 C4 Therapeutics, Inc. (CCCC) Reports Q4 Loss, Misses Revenue Estimates
02/22/24 C4 Therapeutics Inc (CCCC) Reports Full Year 2023 Financial Results and Business Updates
02/22/24 C4 Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights
02/20/24 Earnings Preview: Alector (ALEC) Q4 Earnings Expected to Decline
02/15/24 C4 Therapeutics (CCCC) to Report Q4 Earnings: What's in Store?
02/15/24 C4 Therapeutics, Inc. (CCCC) May Report Negative Earnings: Know the Trend Ahead of Q4 Release
01/11/24 C4 (CCCC) Up 6% on Restructuring Plan to Curb Cash Burn
01/09/24 C4 Therapeutics, Inc. (CCCC)'s Technical Outlook is Bright After Key Golden Cross
01/09/24 C4 Therapeutics Announces 2024 Priorities and Extended Cash Runway to Advance Portfolio of Targeted Protein Degradation Medicines
01/05/24 Axsome (AXSM) Surges 7.8%: Is This an Indication of Further Gains?
01/04/24 C4 Therapeutics Announces Closing of $25 Million Equity Investment by Betta Pharmaceuticals
01/04/24 C4 Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
CCCC Chatroom

User Image diamcertsbs Posted - 8 hours ago

$CCCC Schwab says the Earnings are on 5/7 before the open....

User Image BigSal69 Posted - 10 hours ago

$CCCC https://trendspider.com/markets/symbols/CCCC/

User Image SL_inTally Posted - 10 hours ago

$CCCC what happened to the earnings call for today? MSN is reporting that is on May 9th?

User Image a_zoz Posted - 15 hours ago

$CCCC When ER?

User Image zawojak Posted - 1 day ago

$CCCC

User Image Bill954 Posted - 1 day ago

$CCCC Going back under $5 soon

User Image Tr4648 Posted - 04/30/24

$CCCC earnings will cause this to double

User Image Stevie150570 Posted - 04/30/24

$CCCC 6.55 Today, Come on Bulls

User Image Stock_Titan Posted - 04/29/24

$CCCC C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) https://www.stocktitan.net/news/CCCC/c4-therapeutics-announces-inducement-grant-under-nasdaq-listing-rule-qv236vg3b6kq.html

User Image CreamCheese Posted - 04/24/24

$CCCC hope it bounce

User Image Michelleinvestor Posted - 04/23/24

$CCCC check out $sls this week. News in 7 days or less

User Image BigSal69 Posted - 04/23/24

$CCCC and the same old clown who pumped it up, just sold it off

User Image LabPsycho Posted - 04/23/24

$KRON The move and volume today on $KRON reminds me of a similar trading pattern with $CCCC last Dec when they dropped it hard down to ~ $1.10 on 2.4 million shares, two days later it almost doubled on MRK news then in a few weeks hit almost $10.

User Image zawojak Posted - 04/22/24

$CCCC 10 days to earnings, no trace of life in it ... Is there anyone interested in investing in CCCC?

User Image Professorr Posted - 04/21/24

$CCCC looks interesting if it falls below the trending line it's a short

User Image Golgo13ThePro Posted - 04/20/24

$CCCC 🎵 There's nothing I could do. A total eclipse of the pump 🎶

User Image Michelleinvestor Posted - 04/19/24

$CCCC like money? Throw a buck fitty in the $sls slot machine! https://seekingalpha.com/article/4684757-sellas-life-sciences-group-a-lottery-ticket-with-an-estimated-9x-payout

User Image Fadoman Posted - 04/19/24

$CCCC this is a buy at these levels

User Image Bill954 Posted - 04/18/24

$CCCC $5 INC???

User Image nathw Posted - 04/18/24

$CCCC Anyone alive in here?

User Image Tr4648 Posted - 04/17/24

$CCCC do I guess even the bears have nothing to write about this stock

User Image Tr4648 Posted - 04/16/24

$CCCC back to where it was 2 months ago. I think it went to $11 shortly after hitting this mark

User Image Klipse05 Posted - 04/15/24

$CCCC this world and market have become a fucking joke.

User Image Bill954 Posted - 04/13/24

$CCCC Going under $7 next week??

User Image zzp618 Posted - 04/12/24

$CCCC trend down

User Image Bill954 Posted - 04/11/24

@Gigi1963 @ClayTrader25 @Aces_n_Eights You we're definitely not in my position 6 years ago you have no idea, what I've been through or am going through... I was buying Fannie and Freddie during the financial crisis, I literally tuned $300 into more than $10,000 day trading and flipping from $0.25 to $5 and back down to $0.25 to $4... This year I started with $250 bought $SOUN made 100% in like 5 days flipped it sold... Bought $CCCC at $3.20 flipped made like 80% bought $PLUG sold for 30%....

User Image Noetic83 Posted - 04/10/24

$CCCC PT?

User Image CocaKolla Posted - 04/10/24

$CCCC still HOLDING

User Image DaBullRunner Posted - 04/10/24

$CCCC alert paid off HUGE👇💰💰💰💰💰 Are you missing out on these MONSTER runs? Do you want to be EARLY before the crowd? Hit me up Details on my profile 📲📧

User Image PennySqueeze Posted - 04/10/24

$CCCC oh man this could end badly buy quality $NVDA $AAPL $DKNG $BRK.B

Analyst Ratings
Morgan Stanley Equal-Weight Feb 26, 24
Stifel Buy Feb 23, 24
JP Morgan Neutral Jan 29, 24
Stifel Buy Dec 13, 23
Morgan Stanley Equal-Weight Nov 6, 23
BMO Capital Outperform Nov 3, 23
HC Wainwright & Co. Buy Nov 2, 23
B of A Securities Neutral Oct 9, 23
HC Wainwright & Co. Buy Aug 9, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Anderson Kenneth Carl Director Director Jul 15 Option 3.55 1,424 5,055 90,986 07/18/22
Fisher Stewart Chief Scientific Off.. Chief Scientific Officer Apr 12 Option 4.35 28,084 122,165 71,390 04/12/22
Hirsch Andrew President & CEO President & CEO Apr 12 Buy 8.40 10,000 84,000 10,000 04/12/22
Anderson Kenneth Carl Director Director Jan 26 Option 3.55 2,137 7,586 87,975 01/26/22